Spondyloarthritis & psoriatic arthritis

Self-administered screening questionnaires for spondyloarthritis in inflammatory bowel disease: A systematic review

Semin Arthritis RheumPublished Systematic review

Authors' conclusion

Six self-administered questionnaires have been developed to screen for SpA in IBD patients.

Study context

Population
Patients with inflammatory bowel disease (IBD) screened for spondyloarthritis (SpA)8 studies
Comparison
Self-administered screening questionnaires for SpA in IBD patients
Outcome
Screening performance for SpA
Methodological detailsPRISMA guidelines, COSMIN content validity assessment, 1491 articles screened; last search April 21, 2024
  • PRISMA guidelines
  • COSMIN content validity assessment
  • 1491 articles screened; last search April 21, 2024

Pooled result

As reported in the abstract

GroupSensitivity (highest)Specificity (highest)Positive likelihood ratio (highest post-test probability)
IBIS-Q92.7 %— not stated in the abstract— not stated in the abstract
Queiro's axial questionnaire— not stated in the abstract89.8 %— not stated in the abstract
DETAIL— not stated in the abstract— not stated in the abstractat least 14

Sensitivity (highest)

IBIS-Q92.7 %
Queiro's axial questionnaire— not stated in the abstract
DETAIL— not stated in the abstract

Specificity (highest)

IBIS-Q— not stated in the abstract
Queiro's axial questionnaire89.8 %
DETAIL— not stated in the abstract

Positive likelihood ratio (highest post-test probability)

IBIS-Q— not stated in the abstract
Queiro's axial questionnaire— not stated in the abstract
DETAILat least 14

— not stated in the abstract

Original publication

Self-administered screening questionnaires for spondyloarthritis in inflammatory bowel disease: A systematic review. Semin Arthritis Rheum. Published 12 December 2025. doi:10.1016/j.semarthrit.2025.152890

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.